A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale.

Autor:	Keefe, Richard S. E.1,2 (AUTHOR) richard.keefe@duke.edu, Woods, Scott W.3 (AUTHOR), Cannon, Tyrone D.3,4 (AUTHOR), Ruhrmann, Stephan5 (AUTHOR), Mathalon, Daniel H.6 (AUTHOR), McGuire, Philip7 (AUTHOR), Rosenbrock, Holger8 (AUTHOR), Daniels, Kristen9 (AUTHOR), Cotton, Daniel9 (AUTHOR), Roy, Dooti9 (AUTHOR), Pollentier, Stephane10 (AUTHOR), Sand, Michael9 (AUTHOR)
Zdroj:	Early Intervention in Psychiatry. Oct2021, Vol. 15 Issue 5, p1315-1325. 11p. 2 Diagrams, 2 Charts.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu